China neurosurgery robotic surgical systems market poised for 12% CAGR through 2033, forecasts GlobalData

China neurosurgery robotic surgical systems market poised for 12% CAGR through 2033, forecasts GlobalData

China’s healthcare sector is witnessing substantial investment in robotic technologies, driven by an increasing demand for advanced medical solutions. Against this background, China’s neurosurgery robotic surgical systems market is projected to grow at a compound annual growth rate (CAGR) of 12 per cent between 2023 and 2033, according to GlobalData, a leading data and analytics company.

GlobalData’s robotic surgical systems market size by segments, share, regulatory, reimbursement, installed base and forecast to 2033 report reveals that in the APAC region, China holds a substantial 35 per cent market share for neurosurgery robotic surgical systems in 2023.

Aditi Dakshesh Parikh, medical devices Analyst at GlobalData, says, “A transformational shift in the healthcare sector has occurred due to the rapid integration of robotic systems into neurosurgery. This has accelerated market growth, improved accuracy in identifying and correcting brain abnormalities, reduced the risk of complications, and shortened patient recovery times. In particular, in the treatment of diseases such as brain tumours, epilepsy, and Parkinson’s disease, where precision is crucial for success, these benefits are significant.”

A research team from the University of Hong Kong has recently developed an interactive multi-stage robotic positioner for MRI-guided stereotactic neurosurgery. This compact, lightweight device fits standard imaging head coils and features custom wireless tracking markers and a zero-electromagnetic-interference system for real-time MRI registration. It supports various therapeutic applications, including biopsy, drug delivery, ablation, and catheter placement. Yet to be commercialised, this innovative technology is a significant advancement, enabling precise interventions in procedures such as deep-brain stimulation for treating various neurological conditions.

Parikh concludes, “With continuous technological advancements and increasing investment in healthcare infrastructure, the Chinese market is expected to witness substantial growth in the coming years. The increasing adoption of neurosurgery robotic systems represents a significant step forward in the evolution of neurosurgical procedures, promising better outcomes for patients and advancing the field of neurosurgery.”